Primary non Hodgkin's lymphoma of the brain in non immunosuppressed patients;Les lymphomes malins non hodgkiniens cerebraux primitifs des patients non immunodeprimes

Bulletin du Cancer

Volumn 84, Issue 10, 1997, Pages 976-980

  Blay, Jean Yves ^a  

^a CENTRE LÉON BÉRARD   (France)

Author keywords

Cerebral non Hodgkin's lymphoma

Indexed keywords

ANTINEOPLASTIC AGENT;

BRAIN LYMPHOMA; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER SURGERY; CANCER SURVIVAL; HUMAN; NONHODGKIN LYMPHOMA; REVIEW; TREATMENT OUTCOME;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; CRANIAL IRRADIATION; FEMALE; GLUCOCORTICOIDS; HUMANS; LYMPHOMA, LARGE-CELL, DIFFUSE; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; PROGNOSIS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0030690004     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Henry JM, Heffner RRJ, Dillard SH, et al. Primary malignant lymphomas of the central nervous system. Cancer 1974 ; 34 : 1293-302.
2. Hochbert FH, Miller DC. Primary central nervous system lymphoma. J Neurosurg 1988 ; 68 : 835-53.
3. Murray K, Kun L, Cox J. Primary malignant lymphoma of the central nervous system. Results of the treatment of 11 cases and review of the litterature. J Neurosurg 1988 ; 65 : 600-7.
4. Fine HA, Mayer RJ. Primary central nervous system lymphoma. Ann Int Med 1993 ; 50 : 1093-104.
5. De Angelis LM. Primary central nervous system lymphoma. Dallas, USA : ASCO Educational Book, 1994 ; 236-40.
6. Blay J-Y, Conroy T, Chevreau C, et al. Analysis of 226 primary cerebral lymphomas treated in 10 centers in France between 1978 and 1993. A retrospective study from the Fédération nationale des centres de lutte contre le cancer. Blood 1995 , 10 (suppl. 1) : 275A.
7. Blay J-Y, Conroy T, Chevrea C, et al. Late neurological toxicity after the treatment of primary cerebral lymphoma : multivariate analysis on 226 patients. Proc Am Assoc Clin Oncol 1997.
8. Eby NL, Grufferman S, Flannelly CM, et al. Increasing incidence of primary cerebral lymphoma in the US. Cancer 1988 ; 62 : 2461-5.
9. Ahsan H, Neugut AI, Bruce JW. Trends in incidence of primary brain tumors in USA 1981-1990. Int J Epidemiol 1995 ; 24 : 1078-85.
10. Bignon YJ, Clavelou P, Ramos F, et al. Detection of Epstein-Barr virus sequences in primary brain lymphoma without immunodeficiency. Neurology 1991 ; 41 : 1152-3.
11. 1. The international non Hodgkin's lymphoma prognostic factor project. A predictive model for aggressive primary non Hodgkin's lymphoma. N Engl J Med 1993 ; 329 : 987.
12. Pollack IF, Lundsford D, Flickinger JC, et al. Prognostic factors in the diagnosis and treatment of primary central nervous system lymphoma. Cancer 1989 ; 63 : 939-47.
13. Brada M, Dearnaley D, Norwich A, et al. Management of primary cerebral lymphoma with initial chemotherapy : preliminary results and comparison with patients treated with radiotherapy alone. Int J Radiat Oncol Biol Phys 1 990 ; 18 : 787-92.
14. Watne K, Scott H, Hager B, et al. Primary malignant lymphoma of the brain. Acta Oncologica 1992 ; 31 : 545-50.
15. Blay JY, Lasset C, Carrie C, et al. Multivariate analysis of prognostic factors in patients with non HIV related primary cerebral lymphoma. A proposal for a prognostic scoring. Br J Cancer 1993 ; 67 : 1136.
16. Selch MT, Shimizu KY, De Salles AF, et al. Primary central nervous system lymphoma: results at the UCLA and review of the litterature. Am J Clin Oncol 1 994 ; 17 : 286-93.
17. Glass J, Gruber ML, Cher L, Hochberg FH. Preirradiation methotrexate chemotherapy of primary central nervous system lymphoma : long term, J Neurosurg 1994 ; 81 : 188-95.
18. Socie G, Chauffat-Piprot C, Schlienger M, et al. Primary lymphoma of central nervous system. An unresolved therapeutic problem. Cancer 1990 ; 65 : 322-6.
19. Ervin T, Canellos GP. Successful treatment of recurrent primary central nervous system lymphoma with high-dose methotrexate. Cancer 1980 ; 45 : 1556-7.
20. Neuwelt EA, Frenkel EP, Gumerlock MK et al. Developments in the diagnosis and treatment of primary CNS lymphoma. Cancer 1986 ; 58 : 1609-20.
21. Tomlinson FH, Kurtin PJ, Suman VJ, et al. Primary intracerebral malignant lymphoma : a clinicopathological study of 89 patients. J Neurosurg 1995 ; 82 : 558-66.
22. Loeffler JS, Ervin TJ, Mauch P, et al. Primary lymphomas of the central nervous system : patterns of failure and factors that influence survival. J Clin Oncol 1985 ; 3 : 490-4.
23. Berry MP, Simpson WJ. Radiation therapy in the management of primary malignant lymphoma of the brain. Int J Radiat Oncol Biol Phys 1980 ; 7 : 55-9.
24. Rampen FHJ, Van Andel JG, Sizoo W, et al. Radiation therapy in primary non Hodgkin's lymphoma of the CNS. Eur J Cancer 1980 ; 16 : 177-84.
25. Gonzales DG, Schuster-Uitterhove AU. Primary non Hodgkin's lymphoma of the central nervous system. Cancer 1983 ; 51 : 2048-52.
26. Sagerman RH, Cassdy JR, Chang CH. Radiation therapy for intracranial lymphoma. Radiology 1967 ; 88 : 552-4.
27. Nelson DF; Martz KL, Bonner H et al. Non Hodgkin's lymphoma of the brain : can high dose, large volume radiation therapy improve survival ? Report on a prospective trial by the Radiation Therapy Oncoly Group (RTOG) 8315. Int J Radiat Oncol Biol Phys 1992 ; 23 : 9-17.
28. Helle TL, Britt RH, Colby TV. Primary lymphoma of the central nervous. J Neurosurg 1984 ; 60 : 94-103.
29. Abelson HT, Kufe DW, Skarin AT, et al. Treatment of central nervous system tumors with methotrexate. Cancer Treat Rep 1981 ; 65 (suppl. 1) : 137-40.
30. Cohen IJ, Voger R, Martz S, et al. Successful non-neurotoxic therapy (without radiotherapy) of a multifocal brain lymphomas with a methotrexate, vincristine and BCNU protocol (DEMOB). Cancer 1986 ; 57 : 6-11.
31. Schultz C, Scott C, Wasserman T, et al. Pre-irradiation chemotherapy (CTX) with cytoxan, adriamycin, vincristine and decadron (CHOD) for primary central nervous system lymphoma (PCNSL) : initial report of Radiation Therapy Oncology Group (RTOG) protocol 88-06. Proc Amer Soc Clin Oncol 1994 ; 13 (abstract 485).
32. Ott RJ, Brada M, Flower MA, et al. Measurements of blood-brain barrier permeability in patients undergoing radiotherapy and chemotherapy for primary cerebral lymphoma. Eur J Cancer 1991 ; 27 : 1356-62.
33. De Angelis LM, Yahalom J, Thaler HT, et al. Combined modality treatment for primary CNS lymphoma. J Clin Oncol 1992 ; 10 : 635-43.
34. Blay JY, Bouhour D, Carrie C, et al. The C5R protocol : a regimen of high-dose chemotherapy and radiotherapy in primary cerebral non-Hodgkin's lymphoma of patients with no known cause of immunosuppression. Blood 1995 ; 86 : 2922-9.
35. Neuwelt EA, Goldman DL, Dahlberg SA, et at. Primary CNS lymphoma treated with osmotic blood-brain barrier disruption : prolonged survival and preservation of cognitive function. J Clin Oncol 1991 ; 9 : 1580-90.
36. Desablens B, Gardembas M, Lemevel A, et al. Seven years results of 104 HIV negative primary cerebral lymphomas treated by the POF LCP88 trial. Blood 1996 ; 88 : 567a.
37. Bleyer WA. Neurologic sequelae of methotrexate and ionizing radiation: a new classification. Cancer Treat Rep 1981 ; 65 (suppl. 1) : 89-98.
38. Asai A, Matsutani M, Kohno T, el at. Subacute brain atrophy after radiation therapy for malignant brain tumor. Cancer 1989 ; 63 1962-74.
39. Fine HA. Treatment of primary cerebral central nervous system lymphoma: still more questions than answers. Blood 1995 ; 86 2873-5.